Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Effect of proton pump inhibitors on the outcomes of peptic ulcer bleeding: comparison of event rates in routine clinical practice and a clinical trial.

Lanas A, Polo-Tomas M, García-Rodríguez LA, García S, Arroyo-Villarino MT, Ponce J, Bujanda L, Calleja JL, Calvet X, Feu F, Perez-Aisa A, Sung JJ.

Scand J Gastroenterol. 2013 Mar;48(3):285-94. doi: 10.3109/00365521.2012.758764. Epub 2013 Jan 8.

PMID:
23298283
2.

Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high- or low-risk stigmata.

Lanas A, Carrera-Lasfuentes P, García-Rodríguez LA, García S, Arroyo-Villarino MT, Ponce J, Bujanda L, Calleja JL, Polo-Tomas M, Calvet X, Feu F, Perez-Aisa A.

Scand J Gastroenterol. 2014 Oct;49(10):1181-90. doi: 10.3109/00365521.2014.950694. Epub 2014 Aug 21.

PMID:
25144754
3.

Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial.

Sung JJ, Barkun A, Kuipers EJ, Mössner J, Jensen DM, Stuart R, Lau JY, Ahlbom H, Kilhamn J, Lind T; Peptic Ulcer Bleed Study Group.

Ann Intern Med. 2009 Apr 7;150(7):455-64. Epub 2009 Feb 16.

PMID:
19221370
4.

Safety and tolerability of high-dose intravenous esomeprazole for prevention of peptic ulcer rebleeding.

Kuipers EJ, Sung JJ, Barkun A, Mössner J, Jensen D, Stuart R, Lau JY, Ahlbom H, Lind T, Kilhamn J.

Adv Ther. 2011 Feb;28(2):150-9. doi: 10.1007/s12325-010-0095-5. Epub 2010 Dec 15.

PMID:
21181319
5.

Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.

Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D.

Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. Review.

6.

The prognosis of patients having received optimal therapy for nonvariceal upper gastrointestinal bleeding might be worse in daily practice than in randomized clinical trials.

Fein F, Weber A, Koch S, Festou N, Dupont-Gossard AC, Cervoni JP, Monnet E, Bardou M, Carbonnel F.

Eur J Gastroenterol Hepatol. 2010 Mar;22(3):361-7.

PMID:
20169656
7.

Oral or intravenous proton pump inhibitor in patients with peptic ulcer bleeding after successful endoscopic epinephrine injection.

Tsai JJ, Hsu YC, Perng CL, Lin HJ.

Br J Clin Pharmacol. 2009 Mar;67(3):326-32. doi: 10.1111/j.1365-2125.2008.03359.x. Epub 2008 Dec 10.

8.

Esomeprazole for the treatment of peptic ulcer bleeding.

den Hoed CM, Kuipers EJ.

Expert Rev Gastroenterol Hepatol. 2010 Dec;4(6):679-95. doi: 10.1586/egh.10.66.

PMID:
21108587
9.

High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: a systematic review and meta-analysis of randomized controlled trials.

Wang CH, Ma MH, Chou HC, Yen ZS, Yang CW, Fang CC, Chen SC.

Arch Intern Med. 2010 May 10;170(9):751-8. doi: 10.1001/archinternmed.2010.100. Review.

PMID:
20458081
10.

Effect of oral esomeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers.

Wei KL, Tung SY, Sheen CH, Chang TS, Lee IL, Wu CS.

J Gastroenterol Hepatol. 2007 Jan;22(1):43-6.

PMID:
17201879
11.

Intravenous esomeprazole for prevention of peptic ulcer re-bleeding: rationale/design of Peptic Ulcer Bleed study.

Sung JJ, Mössner J, Barkun A, Kuipers EJ, Lau J, Jensen D, Stuart R, Junghard O, Olsson G; Pub Study Group.

Aliment Pharmacol Ther. 2008 Apr;27(8):666-77. doi: 10.1111/j.1365-2036.2008.03631.x. Epub 2008 Jan 28.

12.

Effect of intravenous proton pump inhibitor regimens and timing of endoscopy on clinical outcomes of peptic ulcer bleeding.

Liu N, Liu L, Zhang H, Gyawali PC, Zhang D, Yao L, Yang Y, Wu K, Ding J, Fan D.

J Gastroenterol Hepatol. 2012 Sep;27(9):1473-9. doi: 10.1111/j.1440-1746.2012.07191.x.

PMID:
22646140
14.

Is routine second-look endoscopy effective after endoscopic hemostasis in acute peptic ulcer bleeding? A meta-analysis.

El Ouali S, Barkun AN, Wyse J, Romagnuolo J, Sung JJ, Gralnek IM, Bardou M, Martel M.

Gastrointest Endosc. 2012 Aug;76(2):283-92. doi: 10.1016/j.gie.2012.04.441. Epub 2012 Jun 12.

PMID:
22695209
15.

Oral proton pump inhibitors are as effective as endoscopic treatment for bleeding peptic ulcer: a prospective, randomized, controlled trial.

Kim JI, Cheung DY, Cho SH, Park SH, Han JY, Kim JK, Han SW, Choi KY, Chung IS.

Dig Dis Sci. 2007 Dec;52(12):3371-6. Epub 2007 May 19.

PMID:
17514424
16.

Intravenous esomeprazole: a pharmacoeconomic profile of its use in the prevention of recurrent peptic ulcer bleeding.

Keating GM.

Pharmacoeconomics. 2011 Jun;29(6):535-43. doi: 10.2165/11207430-000000000-00000. Review.

PMID:
21568358
17.

Effects of intravenous and oral esomeprazole in the prevention of recurrent bleeding from peptic ulcers after endoscopic therapy.

Sung JJ, Suen BY, Wu JC, Lau JY, Ching JY, Lee VW, Chiu PW, Tsoi KK, Chan FK.

Am J Gastroenterol. 2014 Jul;109(7):1005-10. doi: 10.1038/ajg.2014.105. Epub 2014 Apr 29.

PMID:
24777150
18.

Intravenous proton pump inhibitors before endoscopy in bleeding peptic ulcer with high-risk stigmata: a multicentre comparative study.

Andrews CN, Levy A, Fishman M, Hahn M, Atkinson K, Kwan P, Enns R.

Can J Gastroenterol. 2005 Nov;19(11):667-71.

PMID:
16292361
19.

Randomised clinical trial: high-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers.

Chen CC, Lee JY, Fang YJ, Hsu SJ, Han ML, Tseng PH, Liou JM, Hu FC, Lin TL, Wu MS, Wang HP, Lin JT.

Aliment Pharmacol Ther. 2012 Apr;35(8):894-903. doi: 10.1111/j.1365-2036.2012.05047.x. Epub 2012 Feb 28.

20.

Reassessment of Rebleeding Risk of Forrest IB (Oozing) Peptic Ulcer Bleeding in a Large International Randomized Trial.

Jensen DM, Eklund S, Persson T, Ahlbom H, Stuart R, Barkun AN, Kuipers EJ, Mössner J, Lau JY, Sung JJ, Kilhamn J, Lind T.

Am J Gastroenterol. 2017 Mar;112(3):441-446. doi: 10.1038/ajg.2016.582. Epub 2017 Jan 17.

PMID:
28094314

Supplemental Content

Support Center